Boston, MA – January 6, 2014 — Leerink Swann LLC, a leading investment bank, specializing in healthcare, today announced a change in its name to Leerink Partners LLC as part of a rebranding initiative. Founded in 1995, Leerink has long been known for its market leading equity research and sales & trading services to institutional investors. Over the past five years, Leerink has partnered with corporate and investor clients to become a leading capital markets and M&A advisory firm, as well. In 2013, Leerink advised on 12 M&A transactions and executed a record 28 bookrun financings, including 12 initial public offerings, positioning Leerink as one of the leading healthcare underwriters in 2013.
Leerink also grew and advanced its research, sales & trading capabilities in 2013. Institutional Investor named three Leerink research analysts to its “All-America Rising Stars of Wall Street” ranking for 2013 and the firm added both convertible and derivative trading capabilities through key senior hires. Describing the new brand identity, Jeffrey A. Leerink, Founder, Chairman and CEO, stated, “Our rebranding of the firm is much more than a new name, logo and website. It communicates our commitment to partner with our clients to finance their businesses and to identify and effect strategic transactions as they set out to define the future of healthcare.”
About Leerink Partners
Leerink Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. Leerink Partners LLC is a member of FINRA/SIPC. For more information, please visit: www.leerink.com.